skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi. Ceapro is , I believe, a company that is making inroads into the cosmetics industry with natural grains etc and NO animal testing. Do you folks know much about this company. Also, as I do not invest in companies I consider to be ethically questionable, do you have ideas about ethical companies with good growth or income outlooks? Thanks.
Read Answer Asked by dale on January 23, 2017
Q: Hi 5i,
Sorry to go back to one where you have recently given your assessment but I am confused about CZO. Fabrice Taylor's recent Globe article says the stock is 'quoted at a measly 15 times trailing earnings'. He notes that for the last 9 months sales are up over 50% while operating income tripled, and 70% margins with guidance for 20-25% sales growth. He may not use the word cheap but that seems to be the implication. My online broker site pegs it at a P/E of 16.2 after the post-Fabrice article pop. You describe CZO as very promotional with an expensive $3M in sales for the most recent quarter on a $131M market cap. Annualizing the quarterly sales (not foolproof) would give a market cap to sales ratio of about 11. Throw in the high margins and can you get to the indicated P/E? Could you spend a few more words reconciling all this please and maybe on what is the most significant number to watch going forward in this particular case? Thanks!
Read Answer Asked by Lance on December 19, 2016
Q: Hi Peter,
Any idea why Brookfield Infrastructure partners is going down? I was thinking of taking a full position of 5 % rather than diversifying with Stantec etc. Also, what is the reason for stocks such as Hudbay Minerals and Agrium to continue to go up and is this sustainable? I have noticed the canadian banks and insurance especially TD Bank and Manulife have gone up alot lately. Do you think it is time to trim them as they look over bought. Lastly, can you comment on why Ceapro and B2Gold are taking a hit. The big prediction was gold was going to go much higher after Trump, but all of a sudden, gold continues to experience declines. Thanks very much.
Read Answer Asked by umedali on November 15, 2016
Q: Hi Team,

I know the expectations on ceapro are probably VERY HIGH and the recent attention on it is probably pricing it for perfection. On the other hand, it is debt free, adding a new facility, has rising sales and has a patented technology. Could the current price be justified?
Great job as usual guys!!
Read Answer Asked by Marie on August 22, 2016
Q: Hi, Ceapro Inc has garnered a lot of attention in recent months, with mentions of Nutragena, J&J and Jennifer Anniston. Stock appeared to have settled around $1.75-$1.80, but after Mr Peter Imhof made it one of his top picks on BNN, last week, it has shot up by another 25% in 3 days. Bob Mcwhirter mentioned on BNN that co. has built a new plant and would need to grow its revenue 10X to justify market expectations priced in the stock. Could you please provide some perspective on this co. and comment if it deserves this valuation and is worth starting a small position? Thanks
Read Answer Asked by rajeev on July 25, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!